34 phd-position-in-information-retrieval Fellowship positions at University of Oxford
Sort by
Refine Your Search
-
Motor Group, the Centre is led by Oxford strategy faculty Rafael Ramirez (Director) and Trudi Lang (Co-Director). Focusing on a discrete set of six high-impact themes, the Centre contributes significant
-
Motor Group, the Centre is led by Oxford strategy faculty Rafael Ramirez (Director) and Trudi Lang (Co-Director). Focusing on a discrete set of six high-impact themes, the Centre contributes significant
-
communication and presentation skills and the sensitivity to deal with pastoral duties. This is a full-time position, fixed-term for 3 years. Your application should be submitted on Econjobmarket and include a
-
Applications are invited for the post of Senior Research Fellow and Director of the EIT CDT in Fundamentals of AI. This is aa permanent faculty post in the Department of Statistics, and the
-
challenges, from reducing our carbon emissions to developing vaccines during a pandemic. The Department of Psychiatry is based on the Warneford Hospital site in Oxford – a friendly, welcoming place of work
-
include an experimental malaria challenge component, either with falciparum or vivax malaria parasites. This position is offered full-time on a fixed-term contract initially 2 years or until 31 May 2028
-
candidate would demonstrate an interest in pursuing a doctorate as a subsequent career step. The position is not suitable for researchers who already hold a doctorate. You will hold a good first degree in a
-
. This is a full time, fixed term position for 3 years. We are seeking to recruit a Clinical Research Fellow in Rheumatology to work within Nuffield Department of Orthopaedics, Rheumatology and
-
The role is for a Clinical Research Fellow to join an exciting project – DREaMED (Defining, Recognising and Escalating Maternal Early Deterioration): Decreasing inequality through improved outcomes
-
Fungal infections are a growing threat to planetary health and, in human medicine, the elderly and immunocompromised are a high-risk group. Resistance to the few existing treatments is increasingly